Seroprevalence of RSV IgG Antibodies Across Age Groups in Poland After the COVID-19 Pandemic: Data from the 2023/2024 Epidemic Season
<b>Background/Objectives:</b> Respiratory syncytial virus (RSV) is a leading cause of respiratory infections across all age groups, with the greatest burden observed in young children and older adults. The COVID-19 pandemic significantly disrupted RSV circulation, resulting in an immunit...
Saved in:
Main Authors: | Barbara Poniedziałek, Wiktoria Majewska, Katarzyna Kondratiuk, Aleksander Masny, Anna Poznańska, Karol Szymański, Katarzyna Łuniewska, Emilia Czajkowska, Bartosz Mańkowski, Lidia B. Brydak, Krzysztof Tomasiewicz, Robert Flisiak, Piotr Rzymski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/7/741 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seroprevalence of RSV antibodies in a contemporary (2022-2023) cohort of adults
by: Lara I. Teodoro, et al.
Published: (2025-09-01) -
Incidence of Circulating Antibodies Against Hemagglutinin of Influenza Viruses in Epidemic Season 2023/2024 in Poland
by: Katarzyna Kondratiuk, et al.
Published: (2025-07-01) -
Analyzing Differences in Viral Dynamics Between Vaccinated and Unvaccinated RSV Patients
by: Arjan Suri, et al.
Published: (2025-04-01) -
A CLINICAL AND ECONOMICAL ANALYSIS OF THE RESULTS PRODUCED BY THE PROGRAM OF RSV-INFECTION PROPHYLAXIS DURING THE EPIDEMIOLOGICAL SEASON OF 2012/2013 IN MOSCOW
by: V. I. Ignat'eva, et al.
Published: (2013-11-01) -
Exploring Bacopa monnieri phytochemicals as potential RSV inhibitors: An in-silico analysis of key compounds against fusion and glycoprotein targets
by: Pooja Yadav, et al.
Published: (2025-08-01)